Performing drug screening of tissue derived from cancer patient biopsies using physiologically relevant 3D tumour models presents challenges due to the limited amount of available cell material. Here, we present a microfluidic platform that enables drug screening of cancer cell-enriched multicellular spheroids derived from tumour biopsies, allowing extensive anticancer compound screening prior to treatment. (more…)

Interested in ELRIG’s latest free-to-attend networking event in association with Biocity, Scotland?

Hear speakers from industry & academia talk about recent developments in the design of biological 3D structures that enable cells to form or replicate tissues and create the possibilities of validating models of disease to support and drive translational research into Drug Discovery and Drug Development. (more…)

This year’s ‘Advances in Cell and Tissue Culture’ conference will take place over two days on Tuesday 4th and Wednesday 5th December 2018 in the Department of Chemical Engineering and Biotechnology at Cambridge University.

(more…)

The MipTec exhibition at the recent Basel Life conference is a platform to get informed about the latest Life Sciences technologies and services for those active in the field of industry relevant, translational, basic and applied research and development.

(more…)

Goodbye Flat Biology brings together researchers who are interested in the techniques and applications of 3D culture at the cancer biology, engineering and drug development interface.

Theresa Mulholland, of ScreenIn3D, attended the event to present a poster – Microfluidic technology for oncology precision medicine.

(more…)